Cell adhesion molecules in clinical renal transplantation

Transplantation

Volumn 65, Issue 6, 1998, Pages 763-769

  Fuggle, Susan V ^a   Koo, Dicken D H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA1 INTEGRIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOSUPPRESSIVE AGENT; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CLINICAL TRIAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MULTICENTER STUDY; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTEGRINS; KIDNEY TRANSPLANTATION; LEUKOCYTES; SELECTINS; SOLUBILITY;

EID: 0032571299     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803270-00001     Document Type: Article

References (51)

1. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827.
2. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood 1996; 88(9): 3259.
3. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 1996; 88(8): 3010.
4. Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1: a mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 1996; 98(5): 1081.
5. del Pozo MA, Sanchez-Mateos P, Sanchez-Madrid F. Cellular polarization induced by chemokines: a mechanism for leukocyte recruitment? Immunol Today 1996; 17(3): 127.
6. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993; 14(3): 111.
7. Rollins BJ. Chemokines. Blood 1997; 90 (3): 909
8. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995; 128(6): 1243.
9. Duperray A, Languino LR, Plescia J, et al. Molecular identification of a novel binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997; 272(1): 435.
10. Benimetskaya L, Loike JD, Khaled Z, et al. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nat Med 1997; 3(4): 414.
11. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol 1995; 57: 523.
12. Del Maschio A, Zanetti A, Corada M, et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol 1996; 135(2): 497.
13. Brockmeyer C, Ulbrecht M, Schendel DJ, et al. Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. Transplantation 1993; 55(3): 610.
14. Fuggle SV, Sanderson JB, Gray DW, Richardson A, Morris PJ. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys: correlation with intragraft events. Transplantation 1993; 55(1): 117.
15. Gibbs P, Berkley LM, Bolton EM, Briggs JD, Bradley JA. Adhesion molecule expression (ICAM-1, VCAM-1, E-selectin and PECAM) in human kidney allografts. Transpl Immunol 1993; 1(2): 109.
16. Fuggle SV, Carter AS, Gray DW, Morris PJ. Reactivity of the workshop endothelial cell panel mAb with normal tissue and pre-transplant and transplanted kidneys. In: Schossman Sea, ed. Leucocyte typing V, Vol 2. Oxford: Oxford University Press, 1995: 1790.
17. von Willebrand E, Krogerus L, Salmela K, et al. Expression of adhesion molecules and their ligands in acute rejection of human kidney allografts. Transplant Proc 1995; 27(1): 917.
18. Bishop GA, Hall BM. Expression of leucocyte and lymphocyte adhesion molecules in the human kidney. Kidney Int 1989; 36(6): 1078.
19. Nickeleit V, Miller M, Cosimi BA, Colvin RB. Adhesion molecules in human renal allograft rejection: immunohistochemical analysis of ICAM-1, ICAM-2, ICAM-3, VCAM-1, and ELAM-1. In: Lipsky PE, Rothlein R, Kishimoto TK, Faanes RB, Smith CW, eds. Structure, function, and regulation of molecules involved in leukocyte adhesion. New York: Springer Verlag, 1993: 380.
20. Hill PA, Main IW, Atkins RC. ICAM-1 and VCAM-1 in human renal allograft rejection. Kidney Int 1995; 47(5): 1383.
21. Lin Y, Kirby JA, Browell DA, et al. Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cells. Clin Exp Immunol 1993; 92(1): 145.
22. Suranyi MG, Bishop GA, Clayberger C, et al. Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. Kidney Int 1991; 39(2): 312.
23. Waldmann WJ, Knight DA. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol 1996; 148(1): 105.
24. Sedmak DD, Knight DA, Birmingham DA, Huang EH, Waldman WJ. Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994; 144: 683.
25. Sedmak DD, Knight DA, Vook NC, Waldmann JW. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994; 58(12): 1379.
26. De Caterina R, Tanaka H, Nakagawa T, Hauptman PJ, Libby P. The direct effect of injectable cyclosporine and its vehicle, cremophor, on endothelial vascular cell adhesion molecule-1 expression: ricinoleic acid inhibits coronary artery endothelial activation. Transplantation 1995; 60(3): 270.
27. Frishberg Y, Meyers C, Kelly CJ. Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. Kidney Int 1996; 50: 45.
28. Gearing AH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14(10): 506.
29. Stockenhuber F, Kramer G, Schenn G, et al. Circulating ICAM-1: novel parameter of renal graft rejection. Transplant Proc 1993; 25 (1 Pt 2): 919.
30. Bechtel U, Scheuer R, Landgraf R, Konig A, Feucht HE. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine: clinical monitoring of renal allograft recipients. Transplantation 1994; 58(8): 905.
31. Lebranchu Y, Kapahi P, al Najjar A, et al. Soluble E-selectin, ICAM-1, and VCAM-1 levels in renal allograft recipients. Transplant Proc 1994; 26(4): 1873.
32. Lebranchu Y, al Najjar A, Kapahi P, et al. The association of increased soluble VCAM-1 levels with CMV disease in human kidney allograft recipients. Transplant Proc 1995; 27(1): 960.
33. Alcalde G, Merino J, Sanz S, et al. Circulating adhesion molecules during kidney allograft rejection. Transplantation 1995; 59(12): 1695.
34. Peters TG, Shaver TR, Ames JE TV, Santiago-Delphi EA, Jones KW, Blanton JW. Cold ischemia and outcome in 17,937 cadaveric kidney transplants. Transplantation 1995; 59(2): 191.
35. Shoskes DA, Halloran PF. Delayed graft function: etiology, management and long-term significance. J Urol 1996; 155: 1831.
36. Arnould T, Michiels C, Remade J. Hypoxic human umbilical vein endothelial cells induce activation of adherent polymorphonuclear leukocytes. Blood 1994; 83(12): 3705.
37. Rainger GE, Fisher A, Shearman C, Nash GB. Adhesion of flowing neutrophils to cultured endothelial cells after hypoxia and reoxygenation in vitro. Am J Physiol 1995; 269: H1398.
38. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991; 112(4): 749.
39. Rabb H, Mendiola CC, Saba SR, et al. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 1995; 211(1): 67.
40. Haller H, Dragun D, Miethke A, et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996; 50(2): 473.
41. Gianello P, Saliez A, Bufkens X, et al. EUK-134, a synthetic superoxide dismutase and catalase mimetic, protects rat kid neys from ischemia-reperfusion-induced damage. Transplantation 1996; 62(11): 1664.
42. Yin M, Buurman WA, Daemen J-WHC, Kootstra G. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. Transplantation 1996; 61(10): 1443.
43. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994; 91(2): 812.
44. Haug CE, Colvin RB, Delmonico FL, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55(4): 766.
45. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99(11): 2682.
46. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft survival after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125.
47. Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in non-human primates with renal allografts. J Immunol 1990; 144(12): 4604.
48. Le Mauff B, Hourmant M, Rougier JP, et al. Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation 1991; 52(2): 291.
49. Hourmant M, Le Mauff B, Le Meur Y, et al. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation: a pilot study. Transplantation 1994; 58(3): 377.
50. Hourmant M, Bedrossian J, Durand D, et al. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996; 62(11): 1565.
51. Stepkowski SM, Wang ME, Amante A, et al. Antisense ICAM-1 oligonucleotides block allograft rejection in rats. Transplant Proc 1997; 29: 1285.